These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28798112)

  • 1. Children with cancer get more access to experimental drugs.
    Schmidt C
    Science; 2017 Aug; 357(6351):540. PubMed ID: 28798112
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenging the soaring price of cancer medicines: a call for equity and transparency.
    Gonçalves A; Maraninchi D; Vernant JP
    Ann Oncol; 2016 Sep; 27(9):1812-3. PubMed ID: 27154419
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of off-label drugs in cancer care again under review.
    Braud E; Downs CG
    ONS News; 2005 Mar; 20(3):8. PubMed ID: 15794064
    [No Abstract]   [Full Text] [Related]  

  • 4. [New therapeutic strategies in oncology].
    Bohuon C
    Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
    [No Abstract]   [Full Text] [Related]  

  • 5. Learning from exceptional drug responders.
    Mullard A
    Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 7. Availability of experimental therapy outside oncology randomized clinical trials in the United States.
    Hamilton EP; Lyman GH; Peppercorn J
    J Clin Oncol; 2010 Dec; 28(34):5067-73. PubMed ID: 20975070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded Access Allows for Compassionate Use of Investigational Cancer Drugs.
    Miller D
    ONS Connect; 2015 Jun; 30(2):47. PubMed ID: 26137830
    [No Abstract]   [Full Text] [Related]  

  • 11. Children's clinical cancer trials: what needs to change to allow children access to new cancer drugs?
    Moreno L; Pearson AD
    Expert Rev Clin Pharmacol; 2015; 8(6):665-7. PubMed ID: 26307367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT).
    Booth CM; Calvert AH; Giaccone G; Lobbezoo MW; Eisenhauer EA; Seymour LK
    Eur J Cancer; 2008 Jan; 44(1):25-9. PubMed ID: 17845846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearing the air: towards agreement about access to high cost cancer medicines.
    Lipworth W; Kerridge I; Ghinea N; Zalcberg J
    Ann Oncol; 2019 Jan; 30(1):143-146. PubMed ID: 30339243
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing access to investigational drugs.
    Christian M
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):90-1. PubMed ID: 16163167
    [No Abstract]   [Full Text] [Related]  

  • 15. Endpoints and other considerations in phase I studies of targeted anticancer therapy: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT).
    Booth CM; Calvert AH; Giaccone G; Lobbezoo MW; Seymour LK; Eisenhauer EA
    Eur J Cancer; 2008 Jan; 44(1):19-24. PubMed ID: 17890079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point: The Power of Data to (Mis)Guide Policy to Improve Cancer Health Equity.
    Simon MA; Tom LS; Dong X
    J Natl Compr Canc Netw; 2016 Aug; 14(8):1041-2. PubMed ID: 27496119
    [No Abstract]   [Full Text] [Related]  

  • 17. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
    Prowell T
    Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
    [No Abstract]   [Full Text] [Related]  

  • 18. Unproven methods of cancer treatment: H.11.
    CA Cancer J Clin; 1970; 20(3):172-5. PubMed ID: 4988623
    [No Abstract]   [Full Text] [Related]  

  • 19. New initiatives aim to test more cancer drugs for children.
    Brower V
    J Natl Cancer Inst; 2004 Dec; 96(24):1808-10. PubMed ID: 15601634
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development.
    Hermiston TW; Kirn DH
    Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.